13299-1-AP

antibody from Proteintech Group

Targeting: NPPB

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

13299-1-AP

Provider

Proteintech Group

Product name

BNP antibody

Antibody type

Polyclonal

Description

BNP antibody (Cat. #13299-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2.

Zhao R, Cui X, Du H, Wang Z, Liu C, Zhang L, Qi J, Yang D, Yu H, Yan S, Liu W, Sun H, Wang M
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Mar;13(17):e21337

---

Role of EZH2 in regulating c-Myc stability through the E3 ubiquitin ligase HUWE1 in heart failure and its mechanisms.

Yan L, Xie D, Huang T, Zheng H, Huang J, Chen H, Xie Q, Weng G, Zheng F
Cellular signalling 2025 Nov;135:111968

---

Asb10 accelerates pathological cardiac remodeling by stabilizing HSP70.

Lin K, Wei W, Chen S, Gong Y, Wang X, Wang M, Li R, Zhao Y, Xu S, Jin C, Jiang C, Fu G, Li Q
Cell death & disease 2025 May 22;16(1):409

---

SD49-7 attenuates cardiac hypertrophy by upregulation of S100B through KDM4A inhibition.

Zhang Z, Gao M, Yan T, Feng Z, Lu S, Tang L, Li X, Wang W, Yang P, Zhou S, Hu Y, Duan Y, Zhang S
Biochemical pharmacology 2025 Aug 8;242(Pt 1):117218

---

NMN improves cardiac function in SIRT3 knockout mice via the SIRT1/PGC-1α pathway.

Zhao X, He M, He L, Han R, Liu Y
Scientific reports 2025 Aug 7;15(1):28975

---

STING activation in cardiomyocytes drives hypertrophy-associated heart failure via NF-κB-mediated inflammatory response.

Wang L, Zhang S, Liu H, Gao L, He L, Chen Y, Zhang J, Yang M, He C
Biochimica et biophysica acta. Molecular basis of disease 2024 Mar;1870(3):166997

---

MCT4-dependent lactate transport: a novel mechanism for cardiac energy metabolism injury and inflammation in type 2 diabetes mellitus.

Ma XM, Geng K, Wang P, Jiang Z, Law BY, Xu Y
Cardiovascular diabetology 2024 Mar 14;23(1):96

---

Carnosol prevents cardiac remodeling and ventricular arrhythmias in pressure overload-induced heart failure mice.

Fang Z, Lu M, Huang R, Wang G, Yushanjiang F, Jiang X, Li J
Phytotherapy research : PTR 2024 Jul;38(7):3763-3781

---

Qianyang yuyin granule ameliorates mitochondrial dysfunction of hypertensive myocardial remodeling.

Zheng Y, Fang Y, Luo Y, Fan Y, Fang Z
Journal of ethnopharmacology 2024 Dec 5;335:118610

---

Interleukin(IL)-37 attenuates isoproterenol (ISO)-induced cardiac hypertrophy by suppressing JAK2/STAT3-signaling associated inflammation and oxidative stress.

Guo X, Wang P, Wei H, Yan J, Zhang D, Qian Y, Guo B
International immunopharmacology 2024 Dec 5;142(Pt B):113134

---

Baicalin improves isoproterenol-induced cardiac remodeling by regulating the Nrf2-dependent signaling pathway.

Qian K, Song L, Guo JM, Fu D, Shi J, Ma Y, Ge ZJ, Li L, Zhang SQ
BMC cardiovascular disorders 2024 Dec 20;24(1):733

---

Exercise training affects calcium ion transport by downregulating the CACNA2D1 protein to reduce hypertension-induced myocardial injury in mice.

Gao S, Yao W, Zhou R, Pei Z
iScience 2024 Apr 19;27(4):109351

---

G9a inhibition promotes the formation of pacemaker-like cells by reducing the enrichment of H3K9me2 in the HCN4 promoter region.

Xu P, Jin K, Zhou J, Gu J, Gu X, Dong L, Sun X
Molecular medicine reports 2023 Feb;27(2)

---

Effects of Excessive Activation of N-methyl-D-aspartic Acid Receptors in Neonatal Cardiac Mitochondrial Dysfunction Induced by Intrauterine Hypoxia.

Liu Y, Luo Z, Liao Z, Wang M, Zhou Y, Luo S, Ding Y, Liu T, Cao C, Yue S
Frontiers in cardiovascular medicine 2022;9:837142

---

Administration of USP7 inhibitor P22077 inhibited cardiac hypertrophy and remodeling in Ang II-induced hypertensive mice.

Gu YH, Ren KW, Wang Y, Wang SH, Yu XH, Xu LW, Li HH, Bi HL
Frontiers in pharmacology 2022;13:1021361

---

Transient Receptor Potential Vanilloid Type 1 Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Promoting Mitochondria-Associated Endoplasmic Reticulum Membranes.

Wang Y, Li X, Xu X, Qu X, Yang Y
Journal of cardiovascular pharmacology 2022 Sep 1;80(3):430-441

---

Fabrication of SA/Gel/C scaffold with 3D bioprinting to generate micro-nano porosity structure for skin wound healing: a detailed animal in vivo study.

Niu C, Wang L, Ji D, Ren M, Ke D, Fu Q, Zhang K, Yang X
Cell regeneration (London, England) 2022 May 1;11(1):10

---

β3 adrenoceptor agonist mirabegron protects against right ventricular remodeling and drives Drp1 inhibition.

Zhao L, Luo H, Li T, Zhao X, Liu Y
Cardiovascular diagnosis and therapy 2022 Dec;12(6):815-827

---

Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway.

Cui Y, Wang Y, Liu G
Pharmaceutical biology 2021 Dec;59(1):1305-1313

---

The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation.

Xie X, Bi HL, Lai S, Zhang YL, Li N, Cao HJ, Han L, Wang HX, Li HH
Science advances 2019 May;5(5):eaau0495

---

Phenotype and Functional Analyses in a Transgenic Mouse Model of Left Ventricular Noncompaction Caused by a DTNA Mutation.

Cao Q, Shen Y, Liu X, Yu X, Yuan P, Wan R, Liu X, Peng X, He W, Pu J, Hong K
International heart journal 2017 Dec 12;58(6):939-947